Reuters logo
AstraZeneca wins U.S. approval for heart pill
May 6, 2014 / 6:15 AM / 3 years ago

AstraZeneca wins U.S. approval for heart pill

LONDON, May 6 (Reuters) - AstraZeneca Plc said on Tuesday it had won U.S. approval for Epanova, a new pill for heart disease, providing a welcome piece of good news as it fights a $106 billion takeover approach from Pfizer Inc.

Reporting by Ben Hirschler

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below